How brain support cells (astrocytes) cause blood-vessel problems in Alzheimer's

Astrocytes as governing pathological drivers of neurovascular dysfunction in AD

NIH-funded research Massachusetts General Hospital · NIH-11301013

This project focuses on whether brain support cells called astrocytes cause blood-vessel and blood–brain barrier damage in people with Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11301013 on NIH RePORTER

What this research studies

If you or a loved one has Alzheimer's, the team at Massachusetts General Hospital is trying to understand how astrocytes (brain support cells) may drive problems in the brain's blood vessels and barrier. They use laboratory experiments and Alzheimer's mouse models (for example APP/PS1) to change astrocyte behavior and watch effects on blood flow, the blood–brain barrier, and waste clearance. The researchers combine imaging, molecular tests, and genetic tools and may analyze human brain tissue samples when available. The goal is to learn mechanisms that could point to new ways to protect brain blood vessels or improve brain cleaning systems.

Who could benefit from this research

Good fit: People living with Alzheimer's disease or with mild cognitive impairment would be the most relevant group for future treatments informed by this work.

Not a fit: People without Alzheimer's or whose problems are unrelated to vascular or astrocyte dysfunction are unlikely to benefit directly from these findings.

Why it matters

Potential benefit: If successful, this work could point to new targets to protect the brain's blood vessels or blood–brain barrier and help slow cognitive decline in Alzheimer's.

How similar studies have performed: Prior laboratory and animal studies indicate astrocytes can influence blood flow and the blood–brain barrier, but turning those findings into proven Alzheimer's treatments remains early and unproven.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.